Aktiesnakken — Juni 2013
-
kamn man købe aktier deri?
-
ikke noget hk dobbeltnot
ering? -
jeg hader at ligge kontant
-
it is such a waste of resources
-
det er godt man ikke skal ernære sig ved daytraderi.
-
Carnegie er på købersiden i genmab. Dog med meget små positioner indtil videre. Har Carsten mon fundet en kunde ?
-
Ingen må sige til aka at Carsten og Carnegie er gået igang med algo opkøb
-
så går han ud af det gode skind igen
-
Vi elsker Carnegie. Det var dem der startede hele opturen fra kurs 30 til kurs 60
-
Offering of up to 234,052,000 shares in a Rights Issue at a subscription price of NOK 0.25 per Offer Share, each with a nominal value of NOK 0.075, with tradable Subscription Rights for Eligible Shareholders.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind